|
|
33. Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse eventsSara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, original scientific article Keywords: vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism Full text (file, 279,78 KB) This document has more files! More... |
34. Genetic polymorphisms in oxidative stress and inflammatory pathways as potential biomarkers in Alzheimer’s disease and dementiaDavid Vogrinc, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan, 2023, original scientific article Keywords: Alzheimer’s disease, oxidative stress, inflammation, polymorphism, biomarker Full text (file, 1,14 MB) This document has more files! More... |
35. Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson’s diseaseBoštjan Petrič, Sara Redenšek Trampuž, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec, 2023, original scientific article Keywords: Parkinson disease, cognitive impairment, paraoxonase 1, paraoxonase activity, single-nucleotide polymorphisms, iFIT Full text (file, 1,14 MB) This document has more files! More... |
36. Extracellular vesicle-bound DNA in urine is indicative of kidney allograft injuryIvana Sedej, Maja Štalekar, Magda Tušek-Žnidarič, Katja Goričar, Nika Kojc, Polona Kogovšek, Vita Dolžan, Miha Arnol, Metka Lenassi, 2022, original scientific article Keywords: DNA, cell-free DNA, donor-derived DNA, extracellular vesicles, kidney allograft injury, kidney allograft rejection, liquid biopsy, urine Full text (file, 7,14 MB) This document has more files! More... |
37. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping featureSara Redenšek Trampuž, David Vogrinc, Katja Goričar, Vita Dolžan, 2023, original scientific article Keywords: COVID-19, neurodegeneration, Alzheimer’s disease, neuroinflammation, Parkinson’s disease, miRNA, biomarker Full text (file, 3,59 MB) This document has more files! More... |
38. Pharmacogenetic markers of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek, 2019, doctoral dissertation Keywords: Parkinson's disease, pharmacogenetics, dopaminergic treatment, adverse events, genetic polymorphisms, personalized medicine, clinical-pharmacogenetic models Full text (file, 11,02 MB) |
39. Variabilnost genov OPRM1, MIR23B in MIR107 ter njihova povezanost z odvisnostjo od alkoholaUrška Ašič, 2023, master's thesis Keywords: alkohol, genotipizacija, genetska variabilnost, MIR23B, MIR107, odvisnost, OPRM1, sopojavna duševna simptomatika Full text (file, 3,58 MB) |
40. Vpliv variabilnosti gena OPRM1 za opioidni receptor mu 1 na izid zdravljenja s tramadolomZala Vidic, 2021, master's thesis/paper Keywords: genotipizacija, genetska variabilnost, OPRM1, MIR23B, MIR107, tramadol, lajšanje bolečine, neželeni učinki Full text (file, 2,57 MB) |